In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 9, 2006, Pages 3170-3172

  Vera Cabrera, Lucio ^a   Gonzalez, Eva ^a   Rendon, Adrian ^a   Ocampo Candiani, Jorge ^a   Welsh, Oliverio ^a   Velazquez Moreno, Victor M ^a   Choi, Sung Hak ^b   Molina Torres, Carmen ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b Dong A Pharmaceutical Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DA 7157; DA 7218; DA 7867; ISONIAZID; LINEZOLID; OXAZOLIDINONE DERIVATIVE; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NOCARDIA BRASILIENSIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; HUMANS; MADUROMYCOSIS; MICROBIAL SENSITIVITY TESTS; MYCETOMA; MYCOBACTERIUM TUBERCULOSIS; NOCARDIA; OXAZOLES; OXAZOLIDINONES; PHOSPHORIC ACID ESTERS; PRODRUGS; TETRAZOLES;

EID: 33748680963     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00571-06     Document Type: Article

References (10)

1. Fortun, J., P. Martin-Davila, E. Navas, M. J. Perez-Elias, J. Cobo, M. Tato, E. G. De la Pedrosa, E. Gomez-Mampaso, and S. Moreno. 2005. Linezolid for the treatment of multidrug-resistant tuberculosis. J. Antimicrob. Chemother. 56:180-185.
2. Gomez-Flores, A., O. Welsh, S. Said-Fernandez, G. Lozano-Garza, R. E. Tavarez-Alejandro, and L. Vera-Cabrera. 2004. In vitro and in vivo activities of antimicrobials against Nocardia bmsiliensis. Antimicrob. Agents Chemother. 48:832-837.
3. Jones, R. N., J. E. Ross, T. R. Pritsche, and H. S. Sader. 2006. Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) program assessing isolates from 16 nations. J. Antimicrob. Chemother. 57:279-287.
4. López-Martínez, R., L. J. Méndez-Tovar, P. Lavalle, O. Welsh, A. Saul, and E. Macotela-Ruíz. 1992. Epidemiología del micetoma en México: estudio de 2105 casos. Gac. Med. Mex. 128:477-481.
5. Moylett, E. H., S. E. Pacheco, B. A. Brown-Elliott, T. R. Perry, E. S. Buescher, M. C. Birmingham, J. J. Schentag, J. F. Gimbel, A. Apodaca, M. A. Schwartz, R. M. Rakita, and R. J. Wallace, Jr. 2003. Clinical experience with linezolid for the treatment of nocardia infection. Clin. Infect. Dis. 36:313-318.
6. Shinabarger, D. 1999. Mechanism of action of the oxazolidinone antibacterial agents. Expert Opin. Investig. Drugs 8:1195-1202.
7. Vera-Cabrera, L., E. Y. Ochoa-Felix, G. Gonzalez, R. Tijerina, S. H. Choi, and O. Welsh. 2004. In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae. Antimicrob. Agents Chemother. 48:1037-1039.
8. Vera-Cabrera, L., J. Castro-Garza, A. Rendon, J. Ocampo-Candiani, O. Welsh, S. H. Choi, K. Blackwood, and C. Molina-Torres. 2005. In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867. Antimicrob. Agents Chemother. 49:4351-4353.
9. Vera-Cabrera, L., E. Gonzalez, S. H. Choi, and O. Welsh. 2004. In vitro activities of new antimicrobials against Nocardia brasiliensis. Antimicrob. Agents Chemother. 48:602-604.
10. Welsh, O., M. C. Salinas, and M. A. Rodríguez. 1994. Mycetoma, p. 1402-1406. In P. D. Hoeprich, M. C. Jordan, and A. R. Ronald (ed.), Infectious diseases, 5th ed. J. B. Lippincott Company, Philadelphia, Pa.